{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:14:39Z","timestamp":1794244479727,"version":"4.9.0"},"reference-count":52,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK 93094"],"award-info":[{"award-number":["R01 DK 93094"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia. Decades later, the virus may reactivate either spontaneously or after a number of triggering factors to cause herpes zoster (shingles). Varicella and its complications are more severe in the immunosuppressed. The most frequent and important complication of VZV reactivation is postherpetic neuralgia, the cause of which is unknown and for which treatment is usually ineffective. Reactivation of VZV may also cause a wide variety of neurological syndromes, the most significant of which is a vasculitis, which is treated with corticosteroids and the antiviral drug acyclovir. Other VZV reactivation complications include an encephalitis, segmental motor weakness and myelopathy, cranial neuropathies, Guillain\u2013Barr\u00e9 syndrome, enteric features, and zoster sine herpete, in which the viral reactivation occurs in the absence of the characteristic dermatomally distributed vesicular rash of herpes zoster. There has also been a recent association of VZV with giant cell arteritis and this interesting finding needs further corroboration. Vaccination is now available for the prevention of both varicella in children and herpes zoster in older individuals.<\/jats:p>","DOI":"10.3390\/v10110609","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T04:26:39Z","timestamp":1541391999000},"page":"609","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":322,"title":["Clinical Features of Varicella-Zoster Virus Infection"],"prefix":"10.3390","volume":"10","author":[{"given":"Peter G. E.","family":"Kennedy","sequence":"first","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Campus, Glasgow G61 1QH, Scotland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne A.","family":"Gershon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/rmv.362","article-title":"Varicella-zoster virus latency in human ganglia","volume":"12","author":"Kennedy","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3949\/ccjm.74.7.489","article-title":"The protean neurologic manifestations of varicella-zoster virus","volume":"74","author":"Nagel","year":"2007","journal-title":"Cleve Clin. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091016","article-title":"Immune responses to varicella-zoster in the aged","volume":"142","author":"Burke","year":"1982","journal-title":"Arch. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/149.4.647","article-title":"Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine","volume":"149","author":"Berger","year":"1984","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF03210846","article-title":"Varicella-zoster virus human ganglionic latency: A current summary","volume":"16","author":"Kennedy","year":"2010","journal-title":"J. Neurovirol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.95.8.4658","article-title":"Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia","volume":"95","author":"Kennedy","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/viro.1995.1061","article-title":"Configuration and terminal sequences of the simian varicella virus","volume":"207","author":"Clarke","year":"1995","journal-title":"Virology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/vir.0.000128","article-title":"A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation","volume":"96","author":"Kennedy","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1128\/jvi.70.5.2789-2796.1996","article-title":"Varicella-zoster virus (VZV) transcription during latency in human ganglia: Detection of transcripts to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA","volume":"70","author":"Cohrs","year":"1996","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11893","DOI":"10.1128\/JVI.74.24.11893-11898.2000","article-title":"Varicella-zoster virus gene expression in latently infected and explanted human ganglia","volume":"74","author":"Kennedy","year":"2000","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JVI.02745-06","article-title":"Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia","volume":"81","author":"Cohrs","year":"2007","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1128\/JVI.77.12.6660-6665.2003","article-title":"Varicella-Zoster Virus Gene 66 Transcription and Translation in Latently Infected Human Ganglia","volume":"77","author":"Cohrs","year":"2003","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1128\/JVI.01331-12","article-title":"Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death","volume":"86","author":"Ouwendijk","year":"2012","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1128\/JVI.01862-10","article-title":"Varicella-zoster virus transcriptome in latently infected human ganglia","volume":"85","author":"Nagel","year":"2011","journal-title":"J. Virol."},{"key":"ref_16","first-page":"17","article-title":"Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans. Am. Clin. Clim. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41467-018-03569-2","article-title":"A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61","volume":"9","author":"Depledge","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/cid\/civ320","article-title":"Use of saliva to identify varicella-zoster virus (VZV) infection of the gut","volume":"61","author":"Gershon","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11908-014-0407-z","article-title":"Update on varicella zoster virus vasculopathy","volume":"16","author":"Nagel","year":"2014","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_20","unstructured":"Plotkin, S., Orenstein, W., and Offit, P. (2013). Vaccines. Varicella, WB Saunders."},{"key":"ref_21","unstructured":"Knipe, D., and Howley, P. (2013). Varicella-Zoster Virus. Fields Virology, Lippincott, Williams, and Wilkins."},{"key":"ref_22","first-page":"9","article-title":"The nature of herpes zoster: A long term study and a new hypothesis","volume":"58","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jmv.10555","article-title":"Stress-induced subclinical reactivation of varicella zoster virus in astronauts","volume":"72","author":"Mehta","year":"2004","journal-title":"J. Med. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jmv.21173","article-title":"Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts","volume":"80","author":"Cohrs","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1212\/01.WNL.0000148484.19070.4D","article-title":"VZV vasculopathy and postherpetic neuralgia: Progress and perspective on antiviral therapy","volume":"64","author":"Gilden","year":"2005","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.63.7.noc60049","article-title":"Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir","volume":"63","author":"Quan","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13311-016-0430-x","article-title":"Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV)","volume":"13","author":"Kennedy","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jiw110","article-title":"Varicella Zoster Virus and Giant Cell Arteritis","volume":"213","author":"Gershon","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis","volume":"72","author":"Nagel","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajo.2017.12.017","article-title":"Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis","volume":"187","author":"Buckingham","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yexmp.2015.12.007","article-title":"VZV, temporal arteritis, and clinical practice: False positive immunohistochemical detection due to antibody cross-reactivity","volume":"100","author":"Pisapia","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.0000000000001459","article-title":"Varicella-zoster virus claims yet another painful scalp\u2014Giant cell arteritis","volume":"84","author":"Kennedy","year":"2015","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2017.01.053","article-title":"Giant cell arteritis following varicella zoster vaccination","volume":"375","author":"Lotan","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-444-53488-0.00012-2","article-title":"Varicella-zoster","volume":"123","author":"Gilden","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10096-018-3199-5","article-title":"Guillain-Barre syndrome following varicella-zoster virus infection","volume":"37","author":"Islam","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ana.410350505","article-title":"Zoster sine herpete, a clinical variant","volume":"35","author":"Gilden","year":"1994","journal-title":"Ann. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1212\/WNL.0b013e31820a0d5d","article-title":"Zoster sine herpete: It would be rash to ignore it","volume":"76","author":"Kennedy","year":"2011","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1002\/jmv.10325","article-title":"Latent and lytic infection of isolated guinea pig enteric and dorsal root ganglia by varicella zoster virus","volume":"70","author":"Chen","year":"2003","journal-title":"J. Med. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/infdis\/jiy407","article-title":"Varicella-Zoster Virus and the Enteric Nervous System","volume":"218","author":"Gershon","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1984.03350030023016","article-title":"Live attenuated varicella vaccine: Efficacy for children with leukemia in remission","volume":"252","author":"Gershon","year":"1984","journal-title":"JAMA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0163-4453(17)30188-3","article-title":"Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?","volume":"74","author":"Gershon","year":"2017","journal-title":"J. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/vim.2017.0136","article-title":"Varicella Virus Vaccination in the United States","volume":"31","author":"Shaw","year":"2017","journal-title":"Viral Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jpids\/piv044","article-title":"Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994\u20132012","volume":"5","author":"Leung","year":"2016","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study","volume":"63","author":"Kawai","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged >\/= 60 Years","volume":"213","author":"Tseng","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: A 10year review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/11\/609\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:27:41Z","timestamp":1760196461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/11\/609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["v10110609"],"URL":"https:\/\/doi.org\/10.3390\/v10110609","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]}}}